Vanberra Signal

Digital Diagnostics

Curated by Signal

Provider of AI-based real-time diagnostics devices for SARS-CoV-2 testing

Overview

Provider of AI-based real-time diagnostics devices for SARS-CoV-2 testing. It has developed Cantisense device that helps in the detection of infectious diseases like SARS-CoV-2 virus. It is a point-of-care test kit that offers AI-supported data analysis and diagnostics platforms by using biosensor technology. It offers a mobile app that provides real-time diagnostic solutions & enables the identification of human and animal biomarkers. The care test kit provided by the company can be used by clinical and professionals for their use.

Key facts

Founded
2019
Headquarters
Mainz, Germany

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of central blood pressure monitoring device

    Life Sciences TechnologyJena, Germany
  • Provider of software solutions and bioinformatic data analysis services

    Life Sciences TechnologyBerlin, Germany
  • Provider of bioinformatics and NGS data analysis

    Life Sciences TechnologyHeidelberg, Germany

About Digital Diagnostics

What does Digital Diagnostics do?

Provider of AI-based real-time diagnostics devices for SARS-CoV-2 testing.

Where is Digital Diagnostics headquartered?

Digital Diagnostics is headquartered in Mainz, Germany.

When was Digital Diagnostics founded?

Digital Diagnostics was founded in 2019.

Which sector is Digital Diagnostics in?

Digital Diagnostics operates in Life Sciences Technology.

Who are Digital Diagnostics's competitors?

Companies similar to Digital Diagnostics include Redwave Medical, MicroDiscovery, and SciBerg.